Cite
El Rhalete A, Rhazi I, Bensaid A, et al. Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda. Ann Med Surg (Lond). 2021;67:102514doi: 10.1016/j.amsu.2021.102514.
El Rhalete, A., Rhazi, I., Bensaid, A., Diass, S., Kaouini, A., Ounci, E., Abdi, M., Maarad, M., Babouh, C., Alami, Z., Abda, N., Bkiyer, H., & Housni, B. (2021). Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda. Annals of medicine and surgery (2012), 67102514. https://doi.org/10.1016/j.amsu.2021.102514
El Rhalete, Abdelilah, et al. "Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda." Annals of medicine and surgery (2012) vol. 67 (2021): 102514. doi: https://doi.org/10.1016/j.amsu.2021.102514
El Rhalete A, Rhazi I, Bensaid A, Diass S, Kaouini A, Ounci E, Abdi M, Maarad M, Babouh C, Alami Z, Abda N, Bkiyer H, Housni B. Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda. Ann Med Surg (Lond). 2021 Jul;67:102514. doi: 10.1016/j.amsu.2021.102514. Epub 2021 Jun 25. PMID: 34221397; PMCID: PMC8233060.
Copy
Download .nbib